Literature DB >> 886362

HLA in multiple sclerosis. Relationship to measles antibody, mitogen responsiveness and clinical course.

D W Paty, J B Dossetor, C R Stiller, H K Cousin, L Marchuk, J Furesz, D W Boucher.   

Abstract

In our study of multiple sclerosis (MS) patients we have found significant increases in the A3, B7, and DW2 antigens. We have also studied immune responses in these same patients. There was elevation of measles antibodies in MS patients positive for A3, B7, and B18 as compared to MS patients without those antigens. The first study of mitogen responsiveness (31 patients) showed a decreased response in A3, and B7 positive patients. Study of a second and a larger group (62 patients), at a different time, failed to confirm this deficiency. We propose that there is a genetically linked (HLA) T cell deficiency in some MS patients and that this deficiency results in high humoral responses to measles antigens and an evanescent (or cyclical) reduced T cell response to mitogen.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 886362     DOI: 10.1016/0022-510x(77)90020-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Genetic segregation of multiple sclerosis and histocompatibility (HLA) haplotypes.

Authors:  M Alter; J Quevedo
Journal:  J Neurol       Date:  1979       Impact factor: 4.849

2.  HLA and prognosis in multiple sclerosis.

Authors:  B Runmarker; T Martinsson; J Wahlström; O Andersen
Journal:  J Neurol       Date:  1994-05       Impact factor: 4.849

Review 3.  A review of the etiology of multiple sclerosis.

Authors:  V Vella
Journal:  Ital J Neurol Sci       Date:  1984-12

4.  HLA antigens in Italian multiple sclerosis patients.

Authors:  L La Mantia; M T Illeni; C Milanese; A Salmaggi; M Eoli; G Pellegris; A Nespolo
Journal:  Ital J Neurol Sci       Date:  1991-02

5.  HLA antigens and progression of multiple sclerosis. Part II.

Authors:  L Dejaegher; M de Bruyere; P Ketelaer; H Carton
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

Review 6.  Multiple sclerosis.

Authors:  C M Poser
Journal:  Med Clin North Am       Date:  1979-07       Impact factor: 5.456

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.